Achieve Life Sciences Earnings Estimates, EPS & Revenue | NASDAQ:ACHV

Comments

Achieve Life Sciences Inc Earnings Estimates

ACHVNASDAQ

Trade with Public

$4.57

-0.01-0.22%

Last update: Mar 5, 10:19 AM

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Achieve Life Sciences Earnings Estimates, EPS & Revenue | NASDAQ:ACHV

Achieve Life Sciences (ACHV) is scheduled to report Q4 earnings on March 17, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of N/A.

In the most recent quarter (Q3), Achieve Life Sciences reported EPS of $-0.28, missing estimates of $-0.25 by 0.12%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Achieve Life Sciences has missed EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Achieve Life Sciences has averaged an EPS surprise of 0.04% and a revenue surprise of 0.00%.

Earnings Date

Mar 17

EPS Estimate

$-0.270

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–

Achieve Life Sciences Earnings History

Analyze the earnings history of Achieve Life Sciences using advanced sorting and filters.

Achieve Life Sciences (ACHV) Earnings Per Share

The chart below shows Achieve Life Sciences's reported EPS compared to analyst estimates over recent quarters.

Achieve Life Sciences (ACHV) Revenue

The chart below shows Achieve Life Sciences's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Achieve Life Sciences (NASDAQ:ACHV) reporting earnings?

Achieve Life Sciences (ACHV) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.

What were the latest earnings per share (EPS) for Achieve Life Sciences (NASDAQ:ACHV)?

The Actual EPS was $-0.28, which missed the estimate of $-0.25.

What were Achieve Life Sciences’s (NASDAQ:ACHV) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Atrium Therapeutics Inc

NASDAQ:RNA

$16.13

-2.51%

Voyager Therapeutics Inc

NASDAQ:VYGR

$3.93

-4.84%

Burning Rock Biotech Ltd

Silence Therapeutics PLC

NASDAQ:SLN

$5.10

-11.76%

Achieve Life Sciences Earnings Estimates, EPS & Revenue | NASDAQ:ACHV

Achieve Life Sciences (ACHV) is scheduled to report Q4 earnings on March 17, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of N/A.

In the most recent quarter (Q3), Achieve Life Sciences reported EPS of $-0.28, missing estimates of $-0.25 by 0.12%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Achieve Life Sciences has missed EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Achieve Life Sciences has averaged an EPS surprise of 0.04% and a revenue surprise of 0.00%.

Earnings Date

Mar 17

EPS Estimate

$-0.270

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–